1.Should anterior segment imaging devices replace gonioscopy?
Jovell Ian M. Peregrino ; Edgar U. Leuenberger
Philippine Journal of Ophthalmology 2014;39(2):94-96
Glaucoma will continue to be the leading cause
of irreversible blindness worldwide.1,2 A recent metaanalysis done by Tham and coworkers projected an
increase of 74% in the total number of people with
glaucoma, from 64.3 million in 2013 to 76 million by
2020, and to 111.8 million by the year 2040.2
With this
recent forecast, Asia will have the greatest number of
both primary open angle glaucoma and primary angle
closure glaucoma (PACG), comprising 18.8 million
(79.8%) and 9 million (58.4%) respectively.2
Since half
of the world’s PACG will come from Asia, an effective
reduction in the real incidence and prevention of
visual loss from this devastating disease will depend
on the accurate assessment of the anterior chamber
angle and early detection of appositional closure
Gonioscopy
2.Risk factors for conjunctival tube erosion in eyes implanted with Ahmed glaucoma valve in a private eye institution in the Philippines.
Jovell Ian M. PEREGRINO ; Edgar U. LEUENBERGER ; Ma. Imelda Y. VELOSO
Philippine Journal of Ophthalmology 2018;43(2):51-59
Objective:
To identify the risk factors for conjunctival tube erosion (CTE) in eyes implanted with Ahmed®
glaucoma valve (AGV) device
Method:
This is a retrospective study conducted at a private eye institution. Medical records of patients who
underwent AGV implantation surgery from January 2004 to December 2013 were reviewed. Eyes with at least 24
months of follow-up and complete records were included. Several variables from the pre-, intra-, and postoperative
periods were collected. The primary outcome was development of CTE after AGV surgery. Univariable logistic
regression and multivariable analysis were employed.
Results:
Forty-six (46) eyes of 45 patients were included in the study. The mean follow-up was 50.2 months
(range: 24-140 months). Eight (8) eyes developed CTE (17.4%). Univariable logistic regression analysis identified
female gender (P =0.064), presence of diabetes (P =0.083), prior intraocular surgeries (P =0.09), and postoperative
use of antiglaucoma medications (P =0.086) to be marginally significant risk factors for CTE. On multivariable
analysis, only female gender (OR=15.4, P =0.033) and diabetes (OR=14.1, P =0.031) were found to be significantly
associated with CTE.
Conclusion
Risk factors for CTE following AGV implantation include female gender and presence of diabetes.
Human
;
Glaucoma